famotidine has been researched along with Hematemesis in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Hematemesis: Vomiting of blood that is either fresh bright red, or older coffee-ground in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Famotidine was administered at about 1 to 2 mg/kg/day, two times daily to patients weighing more than 10 kg and three times daily to those weighing less than 10 kg." | 1.27 | Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children. ( Iwamoto, H; Miyake, S; Sugio, Y; Yamada, M; Yamashita, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyake, S | 1 |
| Yamada, M | 1 |
| Iwamoto, H | 1 |
| Yamashita, S | 1 |
| Sugio, Y | 1 |
1 other study available for famotidine and Hematemesis
| Article | Year |
|---|---|
Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children.
Topics: Adolescent; Child; Child, Preschool; Disabled Persons; Esophagitis, Peptic; Famotidine; Female; Hema | 1987 |